NCT00000864 - A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

January 31, 2001

Conditions

HIV Infections

Interventions

DRUG

Abacavir sulfate

DRUG

Zidovudine

Trial Locations (13)

Bronx-Lebanon Hosp. IMPAACT CRS, The Bronx

SUNY Upstate Med. Univ., Dept. of Peds., Syracuse

Emory Univ. School of Medicine, Dept. of Peds., Div. of Infectious Diseases, Atlanta

Univ. of Florida Jacksonville NICHD CRS, Jacksonville

UAB, Dept. of Ped., Div. of Infectious Diseases, Birmingham

Univ. of Illinois College of Medicine at Chicago, Dept. of Peds., Chicago

Usc La Nichd Crs, Los Angeles

DUMC Ped. CRS, Durham

Med. Univ. of South Carolina, Div. of Ped. Infectious Diseases, Charleston

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles

UCSD Maternal, Child, and Adolescent HIV CRS, San Diego

HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston

San Juan City Hosp. PR NICHD CRS, San Juan

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH